Brief: Replicel Life Sciences Says Has New Binding Term Sheet With China-Based YOFOTO
02/05/2018 11:11
May 2 (Reuters) - RepliCel Life Sciences Inc RP.V :
* REPLICEL LIFE SCIENCES NOW FINALIZING ITS STRATEGIC
INVESTMENT
PARTNERSHIP WITH CHINA-BASED YOFOTO
* REPLICEL LIFE SCIENCES INC - NOW HAS A NEW BINDING TERM
SHEET
WITH YOFOTO (CHINA) HEALTH INDUSTRY CO. LTD
Source text for Eikon: ID:nPn6Bv4Wna
Further company coverage: RP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Replicel Life Sciences
See all newsBrief: Replicel Life Sciences Announces Reinstatement Of Trading & Conditional Acceptance For Proposed Transaction
Brief: Replicel Life Sciences Says Replicel Announces A Letter Of Intent For Asset Purchase Agreement
Brief: Replicel Announces Binding Term Sheet For Strategic Investment And U.S. Partnership
Brief: Replicel Announces Its Incoming Board Of Directors
Brief: RepliCel Life Sciences Retains Dermatology Sales And Marketing Executive To Guide Global Commercial Strategy For Automated Dermal Injector